Psychiatric Adverse Effects From Prucalopride in a Medically Complex Adolescent
Open Access
- 1 January 2025
- journal article
- case report
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2025 (1) , 6639748
Abstract
Background: Prucalopride is a highly selective, 5‐HT4 receptor agonist that can be used for the treatment of chronic constipation in individuals for whom laxatives fail to provide adequate relief. The current case study describes adverse neuropsychiatric symptoms following the administration of prucalopride in a 15‐year‐old female with a complex physical and mental health history to manage chronic constipation. Case Summary: A single 2 mg dose of prucalopride was prescribed to a 15‐year‐old female to manage her chronic constipation due to a diagnosis of autoimmune enteric neuropathy. Following the oral administration of prucalopride, the patient started experiencing visual and auditory hallucinations, along with suicidal ideation. Prucalopride was ceased, with the patient receiving psychopharmacology and psychological intervention to address the acute onset psychiatric symptoms. Practical Implications: To our knowledge, this is the second documented case of acute onset neuropsychiatric symptoms following the administration of prucalopride. Clinicians should be aware of this possible side effect, particularly if considering administering prucalopride in patients with neurodevelopmental and psychiatric comorbid histories. Increased supervision and monitoring is recommended in these patients if prucalopride is administrated.Keywords
This publication has 15 references indexed in Scilit:
- Safety and Effectiveness of Prucalopride in Children with Functional Constipation with and without Upper SymptomsPediatric Drugs, 2024
- Psychosis in adults with autism spectrum disorder and attention deficit hyperactivity disorder at acute psychiatric wardsThe European Journal of Psychiatry, 2023
- Prucalopride for Treatment of Upper Gastrointestinal Symptoms in ChildrenPediatric Drugs, 2021
- Differential Effectiveness of Atypical Antipsychotics on HallucinationsJournal of Clinical Psychopharmacology, 2021
- Functional Somatic Symptoms in Children and Adolescents2020
- Anxiety in youth at clinical high risk for psychosisEarly Intervention in Psychiatry, 2015
- Rapid Anxiolytic Effects of a 5-HT4 Receptor Agonist Are Mediated by a Neurogenesis-Independent MechanismNeuropsychopharmacology, 2013
- The Association Between Autism Spectrum Disorder and Psychotic Experiences in the Avon Longitudinal Study of Parents and Children (ALSPAC) Birth CohortJournal of the American Academy of Child & Adolescent Psychiatry, 2013
- Paliperidone for irritability in adolescents and young adults with autistic disorderPsychopharmacology, 2012
- Systematic review: cardiovascular safety profile of 5‐HT4agonists developed forgastrointestinaldisordersAlimentary Pharmacology & Therapeutics, 2012